Christian Carlos. Pen 360 Press [P360P].
After two months of collecting samples and showing results, the pharmaceutical company Pfizer raised the efficacy of its vaccine against SARS-CoV-2, the new coronavirus that causes the COVID-19 disease, from 90 percent to 95 percent, which, according to statistical data recently compiled by NBC, has left more than 250 regrettable deaths in the United States.
On Monday, November 9, it was announced that the Pfizer vaccine, in conjunction with the German firm BioNTech, was barely 90 percent effective; however, both companies warned that, once the required studies were completed, there was a high probability that its final efficacy would be different.
The Food and Drug Administration (FDA) will approve its emergency use in the coming days; it would be the first vaccine on the market to combat the COVID-19 pandemic. The Pfizer vaccine is in the 3rd